Answers are grounded in this paper and cite their sources.
Demonstrates a green synthesis method producing spirooxindole products that reduce oxidative stress in human cells, implying potential therapeutic uses.
The integration of sustainable synthesis with biological relevance is a key objective in contemporary medicinal chemistry. Herein, we report a catalyst‐free, one‐pot multicomponent protocol for the rapid synthesis of spirooxindole‐based pseudo‐natural products under mild and environmentally benign conditions. The reaction proceeds efficiently in methanol at room temperature, affording high yields (80%–90%) within 30 min without the need for external catalysts or chromatographic purification, highlighting its operational simplicity and scalability. Mechanistic studies suggest the in situ formation of a stable azomethine ylide, which undergoes a highly diastereoselective [3+2] cycloaddition and enables broad substrate tolerance across electron‐deficient isatins and substituted maleimides. Biological evaluation using a methyl methanesulfonate‐induced oxidative stress model in human lymphocytes revealed distinct structure–activity relationships. Compounds 4c and 4i significantly reduced intracellular reactive oxygen species and restored cell viability close to control levels, identifying them as promising antioxidative leads. Overall, this study demonstrates a sustainable approach to structurally diverse spirooxindole scaffolds with potential relevance to redox‐associated pathologies.
No takes yet. Share an insight, caveat, or question.
Farhanaz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: